BeOne Medicines AG
ONC NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 5, 2026
ET
EPS Est.
1.63
EPS Actual
2.05
Revenue Est.
$1.62B
Revenue Actual
$1.71B
Next Earnings Report
Date
Nov 5, 2026 · Thu
ET Nov 5, 2026 · Thu
Time
11/5 11:00-14:30
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
1.90
Revenue Est.
$1.75B
Company Overview
BeOne Medicines AG (ticker ONC) is listed on NASDAQ with a market cap of about $38.26B. Its next earnings report (FY2026 Q3) is expected on Nov 5, 2026 (ET), Pre-market, with consensus EPS of 1.90. In the last 9 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Dec 31, 2022 → Aug 5, 2026
Dec 31, 2022Range: -30.54 ~ 2.05Aug 5, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 5, 2026 | -- | 1.63 | Above forecast↑2.05 | $1.62B | $1.71B |
| May 6, 2026 | -- | 0.73 | Above forecast↑1.96 | $1.44B | $1.51B |
| Feb 26, 2026 | -- | 1.60 | Below forecast↓0.58 | $1.47B | $1.5B |
| Nov 6, 2025 | -- | 0.72 | Above forecast↑1.09 | $1.45B | $1.41B |
| Aug 6, 2025 | -- | 0.48 | Above forecast↑0.84 | $1.44B | $1.32B |
| May 7, 2025 | -- | -0.71 | Above forecast↑1.22 | $1.25B | $1.12B |
| Feb 27, 2025 | -- | -0.88 | Below forecast↓-1.43 | $1.04B | $1.13B |
| Nov 12, 2024 | -- | -0.88 | Below forecast↓-1.15 | -- | $1B |
| Aug 7, 2024 | -- | -2.10 | Above forecast↑-1.15 | -- | $929.2M |
| Mar 31, 2024 | -- | -- | -2.41 | -- | $751.7M |
| Dec 31, 2023 | -- | -- | -25.53 | -- | $634.4M |
| Sep 30, 2023 | -- | -- | 2.01 | -- | $781.3M |
| Jun 30, 2023 | -- | -- | -3.64 | -- | $595.3M |
| Mar 31, 2023 | -- | -- | -3.34 | -- | $447.8M |
| Dec 31, 2022 | -- | -- | -30.54 | -- | $380.1M |
Original Filings (SEC)
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
